Filing Details
- Accession Number:
- 0001104659-18-071680
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-06 16:03:39
- Reporting Period:
- 2018-12-03
- Accepted Time:
- 2018-12-06 16:03:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649904 | Rhythm Pharmaceuticals Inc. | RYTM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1615856 | Michael Keith Gottesdiener | 500 Boylston Street, 11Th Floor Boston MA 02116 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-12-03 | 563 | $30.00 | 571,476 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- On December 3, 2018, Mr. Gottesdiener sold 563 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Billionaire Hedge Funds
